Special Reports

Retailers and technology vendors convened at the third annual Health, Wellness and Technology Roundtable to discuss what they see in the current technology today, what they expect in 2014 and some of the unmet technology needs.
According to a DSN poll of suppliers conducted in early April titled “DSN Supplier Sentiment Survey — State of Trade Relations,” as many as 55.7% of suppliers don’t feel they are in a “win-win” scenario with their retail partners.
DSN profiles leading pharmacy retailers in the industry.
Drug Store News’ sister publication, Chain Store Age, celebrated in March the winners of its 32nd annual Retail Store of the Year design competition, which recognizes the best in retail and restaurant design from around the world, as well as achievements in sustainability and in-store digital innovation.
Drug Store News’ sister publication Chain Store Age awards the winners of its 32nd annual Retail Store of the Year design competition, which recognizes the best in retail and restaurant design from around the world, as well as achievements in sustainability and in-store digital innovation.     
In December 2013, the Drug Store News Group hosted an exclusive roundtable discussion of leading pharmacy retailers and a select group of key vendors.
DSN breaks down the brands and categories driving the business.
Community pharmacy fills gaps in access and affordability for patients and payers.
The 15th annual Industry Issues Summit, hosted by The Drug Store News Group on Dec. 3, brought together a powerful lineup of some the top minds in the business.
From 2012 to 2017, global spending on medicines will increase from $205 billion to $235 billion, according to IMS Health. By 2017, 36% of the spend will be on generics, a number that is 9% more than the percentage in 2013. As a result of the patent cliff, generic drug manufacturers have thrived while branded pharmaceutical manufacturers have suffered. Branded pharmaceutical manufacturers are expected to suffer even more in the coming years, as many more important patents will lose exclusivity...